Advertisement
Screener

Lite Strategy, Inc. (LITS) Current Assets

2.8 / 5 stars · 68/120 Roast Me

Lite Strategy, Inc. Current Assets

Lite Strategy, Inc. (LITS) had Current Assets of $10.97 million as of 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:AssetsCurrent · last filed 2026-05-13

  • 2026-03-31: Assets, Current $10.97M.
  • 2025-12-31: Assets, Current $10.91M.
  • 2025-09-30: Assets, Current $13.24M.
  • 2025-06-30: Assets, Current $18.29M.
Period endAssets, Current
2026-03-31$10.97M
10-Q · filed 2026-05-13
2025-12-31$10.91M
10-Q · filed 2026-02-17
2025-09-30$13.24M
10-Q · filed 2025-11-14
2025-06-30$18.29M
10-Q · filed 2026-05-13
2025-03-31$20.78M
10-Q · filed 2025-05-13
2024-12-31$24.39M
10-Q · filed 2025-02-12
2024-09-30$27.75M
10-Q · filed 2024-11-12
2024-06-30$40.77M
10-K · filed 2025-09-26
2024-03-31$59.37M
10-Q · filed 2024-05-09
2023-12-31$66.17M
10-Q · filed 2024-02-13
2023-09-30$88.42M
10-Q · filed 2023-11-09
2023-06-30$107.53M
10-K · filed 2024-09-19
2023-03-31$120.48M
10-Q · filed 2023-05-11
2022-12-31$133.44M
10-Q · filed 2023-02-09
2022-09-30$148.91M
10-Q · filed 2022-11-14
2022-06-30$167.13M
10-K · filed 2023-09-26
2022-03-31$183.47M
10-Q · filed 2022-05-23
2021-12-31$200.72M
10-Q/A · filed 2022-05-23
2021-09-30$167.36M
10-Q/A · filed 2022-05-23
2021-06-30$164.82M
10-K · filed 2022-09-08
2021-03-31$176.56M
10-Q · filed 2021-05-06
2020-12-31$194.03M
10-Q · filed 2021-02-04
2020-09-30$203.93M
10-Q · filed 2020-11-10
2020-06-30$208.64M
10-K/A · filed 2022-05-23
2020-03-31$95.40M
10-Q · filed 2020-05-07
2019-12-31$106.44M
10-Q · filed 2020-02-06
2019-09-30$68.05M
10-Q · filed 2019-11-07
2019-06-30$82.20M
10-K · filed 2020-09-09
2019-03-31$85.44M
10-Q · filed 2019-05-09
2018-12-31$95.83M
10-Q · filed 2019-02-07
2018-09-30$94.44M
10-Q · filed 2018-11-08
2018-06-30$104.33M
10-K · filed 2019-08-28
2018-03-31$37.06M
10-Q · filed 2018-05-09
2017-12-31$43.21M
10-Q · filed 2018-02-08
2017-09-30$47.66M
10-Q · filed 2017-11-08
2017-06-30$55.32M
10-K · filed 2018-08-30
2017-03-31$59.52M
10-Q · filed 2017-05-04
2016-12-31$57.82M
10-Q · filed 2017-02-08
2016-09-30$60.64M
10-Q · filed 2016-11-09
2016-06-30$46.75M
10-K · filed 2017-09-05
2016-03-31$50.50M
10-Q · filed 2016-05-05
2015-12-31$54.58M
10-Q · filed 2016-02-05
2015-09-30$58.61M
10-Q · filed 2015-11-06
2015-06-30$64.28M
10-K · filed 2016-09-06
2015-03-31$71.11M
10-Q · filed 2015-05-07
2014-12-31$79.24M
10-Q · filed 2015-02-06
2014-09-30$42.41M
10-Q · filed 2014-11-06
2014-06-30$49.29M
10-K · filed 2015-09-02
2014-03-31$55.54M
10-Q · filed 2014-05-08
2013-12-31$60.66M
10-Q · filed 2014-02-11
2013-09-30$32.11M
10-Q · filed 2013-11-08
2013-06-30$36.03M
10-K · filed 2014-09-09
2013-03-31$24.43M
10-Q · filed 2013-05-09
2012-12-31$27.07M
10-Q · filed 2013-02-12
2012-09-30$3.84M
10-Q · filed 2012-11-13
2012-06-30$6.35M
10-K · filed 2013-09-18
2012-03-31$3.27M
10-Q · filed 2012-05-15
2011-12-31$5.19M
10-Q · filed 2012-02-09
2011-09-30$4.91M
10-Q · filed 2011-11-14
2011-06-30$4.13M
10-K · filed 2012-09-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38